Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

Prioritising disease control and embracing sustainable inhaler innovations will be key to delivering a net zero NHS, writes Edward Piper, medical & scientific affairs director at AstraZeneca UK ...

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...

Review compares patient-important outcomes and assesses evidence among 42 systemic treatments in patients in 93 studies.